Shore Capital Partners and C2Dx acquire Cook Medical’s OHNS portfolio
This comes after CooperCompanies abandoned plans to acquire Cook Medical’s reproductive health business following FTC investigation.
25 January 2024
25 January 2024
This comes after CooperCompanies abandoned plans to acquire Cook Medical’s reproductive health business following FTC investigation.
Elephas’ imaging diagnostics platform is being developed to predict patient response to immunotherapy.
The stand-alone device is designed to replace traditional means of surgical magnification, allowing for higher resolutions and augmented reality overlays.
Phase II of Gate’s zelquistinel will use Becon’s Dreem 3S headband device to conduct exploratory electroencephalogram (EEG) and sleep analyses in patients with major depressive disorder (MDD).
The system utilises artificial intelligence (AI) to transform patient X-rays or computed tomography (CT) images into detailed 3D anatomic models.
Motif plans to use the proceeds from the Series A financing to further the development of the DOT microstimulator.
The new ultrasound method can predict the risk of preterm birth as early as 23 weeks into pregnancy.
Depending on the outcome of Femasys’ FINALE pivotal trial, a non-surgical device for permanent birth control could be available again.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.